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Abstract
Background: Cells transformed by human adenoviruses (Ad) exhibit differential capacities to
induce tumours in immunocompetent rodents; for example, Ad12-transformed rodent cells are
oncogenic whereas Ad5-transformed cells are not. The E1A gene determines oncogenic
phenotype, is a transcriptional regulator and dysregulates host cell gene expression, a key factor in
both cellular transformation and oncogenesis. To reveal differences in gene expression between
cells transformed with oncogenic and non-oncogenic adenoviruses we have performed
comparative analysis of transcript profiles with the aim of identifying candidate genes involved in
the process of neoplastic transformation.
Results:  Analysis of microarray data revealed that a total of 232 genes were differentially
expressed in Ad12 E1- or Ad5 E1-transformed BRK cells compared to untransformed baby rat
kidney (BRK) cells. Gene information was available for 193 transcripts and using gene ontology
(GO) classifications and literature searches it was possible to assign known or suggested functions
to 166 of these identified genes. A subset of differentially-expressed genes from the microarray was
further examined by real-time PCR and Western blotting using BRK cells immortalised by Ad12
E1A or Ad5 E1A in addition to Ad12 E1- or Ad5 E1-transformed BRK cells. Up-regulation of RelA
and significant dysregulation of collagen type I mRNA transcripts and proteins were found in Ad-
transformed cells.
Conclusion: These results suggest that a complex web of cellular pathways become altered in Ad-
transformed cells and that Ad E1A is sufficient for the observed dysregulation. Further work will
focus on investigating which splice variant of Ad E1A is responsible for the observed dysregulation
at the pathway level, and the mechanisms of E1A-mediated transcriptional regulation.
Background
The study of human adenoviruses (Ad) has made major
contributions to our understanding of gene expression,
cell cycle regulation and cancer [1]. The Ad12 serotype
was originally classed as 'highly' oncogenic in the new-
born Syrian hamster model due to its propensity to induce
local tumours within 1 to 2 months following injection by
various routes [2,3]. In contrast, Ad5 does not induce
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tumours in newborn hamsters [4,5]. Furthermore,
although all human Ad serotypes can transform primary
baby rat kidney (BRK) cells in vitro, only BRK cells trans-
formed by the species A human Ads (such as Ad12) can
induce tumour formation in immunocompetent adult
rodents [reviewed in [6]]. In addition, substantial evi-
dence indicates that cells transformed by species A Ads
actively evade the cellular immune system [6]. Investiga-
tion of the mechanisms directing such oncogenesis has
bestowed a greater understanding of cell cycle control and
apoptosis; for example, it is well established that products
of Ad E1A and E1B genes target the retinoblastoma gene
product (pRb) and p53 genes, respectively [5,6]. Binding
of pRb by E1A and subsequent release of E2F plays a cen-
tral role in cell cycle progression and proliferation of
infected cells. In the presence of E1B 55 kDa protein
expression, this deregulated cellular proliferation is
enhanced due to subversion of cell cycle control exerted
by p53. Furthermore E1B-19K, a bcl-2 homolog, sup-
presses apoptosis. Although Rb and p53 are undoubtedly
critical players in cell transformation, in order to gain a
better understanding of the extent of changes involved in
the process of oncogenesis, the challenge is to understand
the extent of dysregulation of all the cellular networks and
gain a more thorough insight of how the immune
response is avoided.
All human Ad serotypes can subvert the apoptotic
response to the presence of foreign viral DNA within the
cell, however only a small subset of Ads possess the ability
to outmanoeuvre the immune surveillance system of
immunocompetent rodents, giving rise to a tumour
resulting from uncontrolled cell division. The only viral
genes found to be necessary and sufficient for cell trans-
formation by Ad5 are the early genes E1A and E1B. The Ad
E1A proteins lack enzymatic activity and are incapable of
directly binding to host cell DNA yet can dysregulate host
cell gene expression by acting as transcriptional activators
or repressors and can also affect the activity of proteins of
the host cell [reviewed in [6]]. Adenovirus E1A has been
shown to reduce levels of surface MHC class I expression
on the surface of rat, human, mouse and hamster Ad12-
transformed cells, compared to cells transformed with
non-oncogenic Ad5 [reviewed in [5]]. However, given the
complexity of interactions and pathways in vivo, it is
unlikely that MHC class I down-regulation alone deter-
mines the oncogenicity of serotypes such as Ad12. In addi-
tion, MHC class I down-regulation does not involve a
region known to be essential for tumorigenesis that con-
sists of 20 amino acids unique to Ad12 E1A and resides
between two regions conserved in both E1A sequences of
the Ad12 and Ad5 serotypes [reviewed in [6]].
The persistence of cells either infected with or transformed
by DNA tumour viruses is dependent not only on the
avoidance of the immune system but also on dysregula-
tion of a complex network of cellular pathways. As a first
step to address this issue, we have examined the global
changes to cellular gene expression that occur as a result
of adenovirus transformation of primary BRK cells. Micro-
array studies of adenovirus-transformed cells [7,8] as well
as cells infected with adenovirus [9-11] or pLPC retrovi-
ruses carrying the adenovirus 12S E1A gene [12] indicate
that numerous host cell genes are targets for dysregula-
tion. We therefore hypothesize that the comparative anal-
ysis of gene profiles from untransformed BRK cells and
BRK cells transformed with Ad12 or Ad5 E1 will, to a large
extent, reveal expression differences between cells trans-
formed with oncogenic versus non-oncogenic adenovirus
serotypes and provide candidate genes and pathways
involved in the processes of transformation and onco-
genicity.
Here, we report the gene expression profiles of normal
BRK cells and BRK-derived cells transformed with the E1
region of adenovirus 12 (Ad12 E1-TC) or Ad5 (Ad5 E1-
TC). Overall 232 genes were differentially expressed in
normal versus Ad-transformed BRK cells. After data nor-
malisation, exclusion of genes with less than a 1.5 average
fold-change in expression and bioinformatics analysis, we
were able to assign identities to 193 out of these differen-
tially expressed transcripts. Gene ontology information
was available for the majority (86%) of the identified
genes and the functional annotation suggests a wide spec-
trum of physiological changes that are likely to corre-
spond to differences between transformed and
untransformed cells. Analysis of steady-state levels of
mRNAs and proteins was performed on a subset of the dif-
ferentially regulated cellular genes and possible roles for
these genes in adenovirus transformation (and onco-
genicity) are proposed.
Results
Analysis of RNA transcript levels from 15,481 genes in cell-
lines transformed with Ad12 or Ad5 E1 region
The microarray study was performed in order to obtain
insight into how transformation with Ad12 or Ad5 E1
region affects levels of expression of RNA in primary BRK
cells. Any change from normal levels may reflect viral
modification of host cell RNA transcription, processing
and/or stability. In total, 15,481 rat genes were screened
by GeneFilters cDNA microarray releases gf300, gf301 and
gf302. Excluding control spots (total genomic DNA,
tgDNA, and β-actin) the total number of genes on gf300,
gf301 and gf302 was 5147, 5184 and 5150, respectively.
Two copies of each rat GeneFilters cDNA microarray filter
set (set A and set B; each comprised of gene filter releases
gf300, gf301 and gf302) were screened in duplicate with
labelled cDNA derived from independent preparations ofBMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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RNA from adenovirus E1-transformed and untransformed
BRK cells.
Identification of 232 differentially expressed cellular genes
Following normalisation, 2829 cDNAs with an expression
value above twice that of background in both duplicate
hybridisations of at least one cell type were selected for
further analysis. Expression ratios of tgDNA between
duplicate samples was consistent with good reproducibil-
ity (median tgDNA ratio: 1.16) and genes whose expres-
sion ratio was greater than ± 1.2 were investigated further.
Consistent with previous studies which show cell surface
expression of β2-m in Ad12-TC is reduced [13], β2-m was
shown by the microarray study to be down-regulated
between 1.2- and 1.34-fold in Ad12 E1-TC and is essen-
tially unaltered in Ad5 E1-TC compared to BRK cells.
However, the expression level of β2-m (clone AA818265)
was below that of twice background in any of the hybrid-
izations so was not reported in Table 1. In addition, cDNA
clones for various alleles of MHC Class I heavy chain were
also present on the arrays. However, although one clone
(AI072399) showed upregulation of approximately 1.5-
fold in Ad12 E1-TC compared to untransformed BRK
cells, this was only apparent in filter set B and not filter set
A so was not taken as significant; in contrast the upregula-
tion in Ad5 E1-TC compared to untransformed BRK cells
was of low variability (Table 1). Most of the cDNA clones
with signals above twice that of background were below
the usual 2-fold threshold used by microarray studies to
define genes that are dysregulated (Figure 1). Due to the
low sensitivity of the arrays, it was decided to set the
threshold of fold-change to 1.5.
Overview of alterations in cellular gene expression 
induced by Ad-transformation
A conservative 1.5 fold change in gene expression
between two or more cell types was used for further anal-
ysis, yielding 232 differentially expressed transcripts.
Excluding expression ratios for duplicates associated
with high variability (coefficient of variation of 25% and
higher), the total number of RNA transcripts with known
identities altered between Ad5 E1-TC and Ad12 E1-TC
was 116. In comparison to untransformed BRK cells, 123
RNA transcripts of known identities were differentially
expressed in the Ad E1-transformed cells with the major-
ity of this dysregulation occurring in BRK cells stably
transformed with Ad5 E1. A small subset of eleven RNA
transcripts of known gene identities showed dysregula-
tion compared to levels of expression in untransformed
BRK cells as a result of the process of transformation by
either Ad5 or Ad12 E1.
Analysis of cellular functions targeted by Ad-
transformation
The Additional file 1 summarises all of the differentially
regulated transcripts, with expression levels in Ad5 and 12
E1-TC compared to each other and to untransformed BRK
cells. In an attempt to identify cellular functions that are
predominantly affected by Ad transformation, we
searched the list of dysregulated genes for statistical over-
representation of functional classes. Gene information
Table 1: Real-time PCR primer combinations used to amplify genes of interest.
NCBI accession 
(cDNA clone)
NCBI accession for 
mRNA record
Primer Sequence of primer Position Size (bp)
AI044043 NM_001009172.2 ZBTB22 (F) 5'-GAGAGCCCGAGGCTACCCT-3' 1204 – 1222 74
ZBTB22 (R) 5'-CCTGTTCCTCCCCCTTTTCT-3' 1278 – 1259
AI059162 NM_022605.1 HPSE (F) 5'-GGCTCTCCACGGCTTCG-3' 270 – 286 65
HPSE (R) 5'-GGTGCCGCCAAATCTCAA-3' 335 – 318
AI145841 NM_199267.2 RelA (F) 5'-GGCATGCGTTTCCGTTACA-3' 152 – 170 68
RelA (R) 5'-ATCTGTGCTTCTCTCCCCAGG-3' 220 – 200
AI058327 XM_576071.1 MLK1 (F) 5'-ACCCCAGCTGCTACCCG-3' 359 – 375 71
MLK1 (R) 5'-CGATGATCTCCTCCAGGGTTAG-3' 430 – 409
AA924727 Z78279.1 COL1A1 (F) 5'-AAAACGGGAGGGCGAGTG-3' 228 – 245 80
COL1A1 (R) 5'-GGTCCCTCGACTCCTATGACTTC-3' 308 – 286
AI145995 AY648296.1 PPP1R1A (F) 5'-AGACTCAGGAGCAGCGTGGT-3' 559 – 578 65
PPP1R1A (R) 5'-CCAGTGGTAGCATGTGGGC-3' 624 – 606
AI044118 NM_001107425.1 NFAT5 (F) 5'-CCTTTAAGGATGCGCTCCAA-3' 13098 – 13117 77
NFAT5 (R) 5'-CAGGGAGGAAAAGAAGAGAGTGAA-3' 13151 – 13174
The NCBI accession numbers for the cDNA clones on the filters used in the initial microarray study are listed with the accession numbers for the 
corresponding mRNA records identified by bioinformatics analysis. Abbreviations for primers correspond to the gene symbols of the target 
genes; zinc finger and BTB domain containing 22 (ZBTB22), V-rel reticuloendotheliosis viral oncogene homolog A (avian) (RelA), mixed-lineage 
kinase 1 (MLK-1; synonym MAP3K9), collagen type 1, alpha 1 (COL1A1), protein phosphatase regulatory (inhibitor) subunit 1A (PPP1R1A) and 
Nuclear factor of activated T-cells 5 (NFAT5). Positions of the forward and reverse primers within the mRNA sequence are given in base pairs 
(bp).BMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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was available for 193 clones, whereas the genes for 39
clones had not been identified (Additional file 1). Using
gene ontology (GO) classifications and literature
searches, known or suggested functions were used to clas-
sify 115 of the identified genes into thirteen defined cate-
gories: signal transduction; transcription; stress &
immune response; cell cycle and proliferation; matrix, cell
adhesion and cytoskeleton; transport; muscle contraction;
visual perception and related disorders; protein metabo-
lism; protein ubiquitination; apoptosis; mRNA processing
and carbohydrate metabolism (Additional file 1 and Fig-
ure 2).
To identify signalling pathways involved in adenovirus
transformation, data sets comprised of gene expression
ratios were analysed by Ingenuity. The Ingenuity Path-
ways Analysis (IPA) is a system that transforms large data
sets into a group of relevant networks containing direct
and indirect relationships between genes based on known
interactions in the literature. It was possible to map 111
out of the 232 dysregulated targets with certainty to the
IPA knowledge base: 66 of the mapped genes were eligible
for network analysis and 51 were eligible for functions
and pathways analysis. Genetic networks were created by
the IPA network generation algorithm from lists of fold-
change expression in Ad5 E1-TC compared to untrans-
formed BRK cells, Ad12 E1-TC compared to untrans-
formed BRK cells and Ad12 E1-TC compared to Ad5 E1-
TC. Comparative analysis across all results was also per-
formed and results were analysed in terms of biofunction
(Figure 3) and canonical pathway (Figure 4).
From this analysis, six genes indicative of defined biolog-
ical processes were selected for further study at the mRNA
level by real-time PCR; V-rel reticuloendotheliosis viral
oncogene homolog A (avian) (RelA), zinc finger and BTB
domain containing 22 (ZBTB22), nuclear factor of acti-
vated T-cells (NFAT5), collagen type 1 alpha 1 (COL1A1),
mixed-lineage kinase 1 (MLK1; synonym MAP3K9) and
protein phosphatase regulatory (inhibitor) subunit 1A
(PPP1R1A). The expression levels of these mRNA tran-
scripts were investigated in the Ad E1-TCs used for the
microarray study and also in BRK cells immortalised with
Ad12 (Ad12 E1A-TC) or Ad5 E1A (Ad5 E1A-TC) alone.
Expression of COL1A1 was investigated at the protein
level by immunofluorescence microscopy and expression
of RelA, MLK1 and PPP1R1A was also investigated at the
protein level using cell lysates derived from the previously
mentioned cell-lines and also from cells transformed with
inactivated Ad5 (Ad5-TC) or inactivated Ad12 (Ad12-TC).
Relative levels of E1A expression in these cell lines are
indicated in figure 5. Differential splicing of the E1A tran-
script and phosphorylation of the E1A protein gives rise to
several bands ranging from approximately 35 to 47 kDa
[14]. The cell line transformed with inactivated Ad5
showed the highest level of E1A expression in comparison
with the cell lines transformed with Ad5 E1 or E1A alone.
This could be related to the number of copies of the viral
DNA sequences that have been integrated in each cell line.
Previous studies have shown that adenovirus DNA inte-
grates at multiple sites (from around 5 to 30 copies of the
viral genome per cell) and these are subject to methyla-
tion and loss/rearrangement, such that only the trans-
forming (E1A and E1B) are constitutively expressed in the
transformed cell thus driving cell proliferation [15].
Expression of E1A in cell lines immortalised by the AccI-
H fragment corresponding to the 4.7% of the Ad12
genome (Ad12 E1A-TC) or the HpaI-E fragment corre-
sponding to the left-terminal 4.5% of the Ad5 genome
(Ad5 E1A-TC) is lower than that shown by cell lines trans-
formed by the entire E1 region, in agreement with previ-
ous observations that the E1B region acts to increase the
frequency and stability of transformation by E1A [16].
The lowest levels of E1A expression are in the Ad5 E1A
immortalised cell-lines; probably due to the absence of
the poly (A) signal of E1A in the HpaI-E fragment of the
Ad5 genome used to immortalise this cell line [17].
Genes dysregulated in Ad5 E1-TC relative to 
untransformed BRK cells
Functional analysis of the Ad5 E1-TC vs BRK dataset
showed that the most significant disease which was asso-
ciated with the mapped genes was cancer, consistent with
the transformed phenotype. Eleven genes from the sub-
mitted expression dataset (CD3G, HPSE, TFAP2A,
COL1A1, STMN1, CD19, GADD45B, MTA3, TFPI, ATM,
EGFR) met the threshold p-value of 0.05 (actual p-values
range from 4.64 × 10-4 to 3.30 to 10-2), so are classified in
this high-level category by IPA (Figure 3a). Our results
agree with previous microarray results indicating up-regu-
lation of GADD45B as a result of adenovirus 2 infection
of HeLa cells [9]. In addition, in concordance with previ-
ously findings that suggest Ad5 E1 induces down-regula-
tion of both EGFR [18,19] and COL1A1 [20], our
microarray results showed down-regulation of both EGFR
(2-fold) and COL1A1 (over 2-fold) in Ad5 E1-TC com-
pared to untransformed BRK cells (Additional file 1).
COL1A1 is the most highly differentially expressed target
involved in cellular adhesion as identified by the microar-
ray study and was investigated further. Significant down-
regulation of COL1A1 in both Ad12 E1-TC and Ad5 E1-
TC compared to untransformed BRK cells was observed at
the RNA level by real-time PCR and at the protein level by
immunofluorescent antibody staining (Figure 6).
A summary of the five top scoring networks generated by
IPA based on the fold-change in gene expression in Ad5
E1-TC compared to BRK cells shows that EGFR and
COL1A1 are part of the highest scoring network of genes
(Figure 7a, b). The most significant function for this net-BMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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work is cancer, with twelve targets dysregulated over 1.5-
fold (ATM, CD19, EGFR, MTA3, PAK4, SRF, STMN1,
TFAP2A, HPSE, GADD45B, RDX, and COL1A1) mapped
to this network being classified in this disease category
with p-values ranging from 5.31 × 10-6 to 1.43 × 10-2. The
process associated with cancer that is most significantly
affected by the dysregulated genes in this network is the
category of developmental process of tumour cell lines (p-
value 5.31 × 10-6). This category encompasses an assort-
ment of findings involving the effect of dysregulation on
the growth and differentiation of tumour cells: ATM pro-
tein increases cellular growth [21] and SRF and TFAP2A
increase differentiation [22,23], whereas up-regulation of
CD19 and down-regulation of EGFR are associated with a
decrease in cellular growth [24,25].
PPP1R1A is also present in the highest scoring network
(Figure 7b). PPP1R1A inhibits PP1, a major serine/threo-
nine protein phosphatase that plays roles in diverse path-
ways, namely carbohydrate metabolism, cell cycle,
protein synthesis, muscle contraction and neuronal sig-
nalling. Protein phosphatase inhibitor 1 mRNA is widely
expressed in mammalian tissue and, when phosphor-
ylated by cAMP-dependent protein kinase (PKA) on Thr-
35, the protein product PPP1R1A (also known as inhibi-
tor-1) is a potent and specific protein phosphatase 1
(PP1) inhibitor [26]. PPP1R1A is closely related in terms
of both structure and function to the more extensively
investigated dopamine and cyclic AMP regulated phos-
phoprotein of relative molecular mass 32,000 (DARPP-
32), which is predominantly found in the cytoplasm of
cDNA microarray analysis of differential gene expression between non-tumorigenic Ad5 E1-TC, tumorigenic Ad12 E1-TC and  untransformed BRK cells Figure 1
cDNA microarray analysis of differential gene expression between non-tumorigenic Ad5 E1-TC, tumorigenic 
Ad12 E1-TC and untransformed BRK cells. A. Summary of the rat GeneFilters microarray analysis. B. Distribution of dif-
ferential gene expression after normalisation for all data points in Ad E1-TC relative to untransformed BRK cells. Number of 
genes represents those that were above twice that of the array background in at least one set of duplicate cell types.
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neurons of the neostriatum [26]. The microarray study
suggested that levels of PPP1R1A were increased nearly 2-
fold in Ad5 E1-transformed cells over untransformed BRK
cells, which was confirmed by the real-time PCR data. Up-
regulation of PPP1R1A at the protein level in Ad5-TC, Ad5
E1-TC and Ad5 E1A-TC was also observed (Figure 8a).
Many of the pathways in the merged networks shown in
Figure 7c converge on FOS, one of the downstream effec-
tors of the MAPK/Erk signalling cascade involved in
growth and differentiation, which the comparative analy-
sis suggests is significantly dysregulated in the Ad5 E1-TC
(Figure 4). Expression of c-fos is suppressed in some
human tumours [27] and also in rat embryo fibroblast
cells transiently transfected or stably transformed by Ad
E1A and Ras, acting on chromatin remodelling factors
[28]. The extracellular signal-regulated kinase (ERK) path-
way is one of three major mammalian mitogen-activated
protein kinase (MAPK) signalling pathways; the others
being the p38 MAPK pathway, and the c-Jun NH2-termi-
nal kinase (JNK) pathway.
A component of the JNK pathway, MAP3K9, was classed
as the highest scoring mapped molecule by IPA assess-
ment of fold-change regulation in Ad5 E1-TC compared
to untransformed BRK cells and plays a role in the merged
high scoring networks (Figure 7c). MAP3K9 (synonym
MLK1) is a member of the MLK family of serine/threonine
kinases and is known to activate the JNK pathway by
phosphorylating (activating) MKK7 (symbol MAP2K7)
upstream of JNK [29]. MLK1 is thought to be activated by
the small GTP binding proteins Rac1 or Cdc42. As Rac1 or
Cdc42 are known to activate both the JNK and the p38
pathways, it has been suggested that MLK1, like MLK3, is
capable of activating both the JNK and the p38 pathway
by activating MKK4. Several lines of evidence suggest that
over-expression of c-Jun by the JNK pathway plays an
essential role in transformation and tumorigenesis [30].
Furthermore, MLK1 has been found expressed at the
mRNA level in epithelial tumour cell lines of colonic,
breast and esophageal origin [31].
The microarray data suggested that MLK1 is up-regulated
in Ad5 E1-transformed cells compared to untransformed
BRK cells by 2.39-fold (Additional file 1) which was con-
firmed by real-time PCR (Figure 8b). Significant up-regu-
lation of MLK1 at the protein level was observed in Ad5-
TC, Ad5 E1-TC and Ad5 E1A-TC. The elevated expression
of MLK1 in adenovirus-transformed cells in comparison
to BRK cells could be contributing to activation of the JNK
pathway leading to the transformed phenotype.
Significantly dysregulated transcripts can be further characterised by gene ontology Figure 2
Significantly dysregulated transcripts can be further characterised by gene ontology. Pie charts showing gene 
ontology analysis of the transcripts differentially expressed as a result of Ad transformation: Ad12 E1-TC compared to untrans-
formed BRK cell line (neoplastic transformation); Ad12 E1-TC compared to Ad5 E1-TC (oncogenic transformation compared 
to non-oncogenic transformation) and Ad5 E1-TC compared to untransformed BRK cell line (non-oncogenic transformation). 
It was possible to classify the majority of genes in to categories defined by GO biological processes with reference to the 
DAVID, KEGG and GenMAPP databases (see Materials and Methods). The largest category is that containing gene products 
that play roles in signal transduction and transcription.
Ad12 E1-TC compared to                        Ad12 E1-TC compared to Ad5 E1-TC
untransformed BRK cells
Ad5 E1-TC compared to     
untransformed BRK cells
GO process
Signal transduction
Transcription
Stress and immune response
Cell cycle and proliferation
Matrix, cell adhesion and cytoskeleton
Transport
Muscle contraction
Visual perception and related disorders
Protein metabolism
Protein ubiquitination
Apoptosis
mRNA processing
Carbohydrate metabolism
OtherBMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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Genes dysregulated in Ad12-TC relative to untransformed 
BRK cells
Notably fewer genes were found to be dysregulated by
over 1.5 fold by Ad12 E1 transformation of BRK cells com-
pared to Ad5 E1 transformation (Figure 1) and none of
the networks returned by IPA overlap (Figure 9a). The top
scoring network (p-value 1 × 10-9: figure 9b) generated by
IPA analysis of genes dysregulated in Ad12 E1-TC com-
pared to untransformed BRK cells only contains two
mapped molecules dysregulated over 1.5-fold (COL1A1
and PLAT) that are classified as associated with cancer.
Both COL1A1 and PLAT have been found to increase the
proliferation of tumour cells [32,33]. Up-regulation of
COL1A1 is involved in progression of gastric carcinoma
[34] and the methylation status of the COL1A1 promoter
is inversely proportional to COL1A1 expression in human
cancer cell lines [35], so it is possible that dysregulation of
COL1A1 is an effect of the chromatin remodelling capa-
bility of E1A. Down-regulation of COL1A1 protein was
observed in both Ad5 E1-TC and Ad12 E1-TC compared
to untransformed BRK cells (Figure 6). A difference
between the invasive properties of Ad12- compared to
Ingenuity comparative analysis of dysregulated targets by biofunction Figure 3
Ingenuity comparative analysis of dysregulated targets by biofunction. Biofunctional analysis of significant dysregula-
tion associated with (a) disease and disorders, (b) molecular and cellular functions and (c) physiological system development 
and function. The significance value associated with each category is a measure of the likelihood that the association between 
dysregulated transcripts and a given process or pathway is due to random chance. The y-axis of each graph shows the signifi-
cance, expressed as the negative exponent of the p-value calculation for each category, increasing with bar height.
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Ad5-TC would be expected as Ad12-TC can form tumours
in both immunocompetent and immunodeficient mice.
Ad12-TC cells are known to prefer attachment to collagen
type IV over collagen type I [36], but to what extent this
affects the metastasis of these cells is unknown. Interest-
ingly, collagen type IV expression is affected by one of the
targets dysregulated uniquely in Ad12-TC cells; tissue-type
plasminogen activator (PLAT), a secreted serine protease
which plays a pivotal role in ECM production and degra-
dation. The main role of PLAT is to convert the proenzyme
plasminogen to plasmin. Plasmin directly degrades com-
ponents of the ECM and amplifies this effect by activating
matrix metalloproteinases (MMPs) [37,38]. Given the
importance of PLAT for ECM homeostasis, presumably
the up-regulation of PLAT mRNA, which is associated
with human pancreatic adenocarcinoma [39] and colorec-
tal cancer [40] contributes to tumour metastasis. PLAT
was found to be up-regulated over 1.5-fold by Ad12 E1
transformation but not significantly dysregulated by Ad5
E1 transformation (Additional file 1).
The two other genes in the highest scoring network that
were dysregulated in Ad12 E1-TC compared to untrans-
formed BRK cells were stromal antigen 1 (STAG1: a com-
ponent of the p53 signalling pathway that plays a role in
the cell cycle as it encodes a component of cohesion) and
Hop homeobox (HOPX). Studies in transgenic mice sug-
gest that, although incapable of directly binding to DNA,
HOPX acts as a repressor of serum response factor (SRF)
dependent transcription by recruiting histone deacetylase
(HDAC) activity [41]. The loss of human HOPX (syno-
nyms NECC1 and LAGY) expression evident in choriocar-
cinoma is thought to be involved in malignant conversion
of placental trophoblasts and has lead to the suggestion
that HOPX is a candidate tumour suppressor gene [42].
Furthermore, a link between human HOPX and lung can-
cer has also been proposed, based on the observation that
this gene was significantly down-regulated in primary
lung tumours compared to normal lung tissue samples
[43]. Interestingly, uterine expression of HOPX in the pro-
gesterone receptor knockout (PRKO) mouse has been
found to be increased by injection of progesterone [44]; a
steroid hormone known to decrease the risk of developing
uterine cancer.
Genes dysregulated in Ad12-TC relative to Ad5-TC
As transformation by Ad12 E1 is highly oncogenic com-
pared to transformation exerted by the nonocogenic sero-
type, investigation of differences in gene expression
between Ad12-TC and Ad5-TC should provide a founda-
tion that allows mapping and identification of genes
involved in neoplastic transformation. This section pro-
vides insight into the comparative expression of genes in
Ad12 E1-TC compared to Ad5 E1-TC in terms of networks.
Canonical signalling pathways affected by adenovirus transformation Figure 4
Canonical signalling pathways affected by adenovirus transformation. Ingenuity comparative analysis revealed several 
significant canonical signalling pathways affected by the dysregulation of transcripts in non-oncogenic transformation of BRK 
cells (Ad5 E1-TC compared to untransformed BRK cells), neoplastic transformation of BRK cells (Ad12 E1-TC compared to 
untransformed BRK cells) and neoplastic compared to non-oncogenic transformation (Ad12 E1-TC compared to Ad5 E1-TC).
Ad5 E1-TC compared to untransformed BRK cell line
Ad12 E1-TC compared to untransformed BRK cell line
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However, it is important to note that any difference
between the response to Ad12 E1 and Ad5 E1-TC in vivo
will involve additional factors; for example, factors
involved in the immune response of the recipient animal
to transformed cells are not considered here.
There is considerable overlap between the top five net-
works that scored highest by IPA (Figure 10), with the
majority of molecules in the merged network associated
with cancer (p-value range of 3.98 × 10-15 to 1.85 × 10-6).
A total of 56 molecules are annotated as affecting neopla-
sia and eight of these are dysregulated over 1.5 fold in
Ad12-TC compared to Ad5-TC: down-regulation of ATM,
CD19, CD3G, GADD45B, HPSE, TFAP2A and TFPI was
observed, whereas levels of EGFR were found to be up-reg-
ulated (Additional file 1).
The microarray results also suggested significant down-
regulation of two components of the p53 signalling path-
way in Ad12-TC compared to Ad5-TC; ATM and
GADD45B. Expression of these targets was not signifi-
cantly dysregulated in Ad12-TC compared to BRK cells,
Relative levels of E1A expression in transformed cell lines Figure 5
Relative levels of E1A expression in transformed cell lines. Levels of E1A expression in the transformed cell lines were 
assessed by Western Blot. Intensities were corrected for average background and normalised to GAPDH expression calcu-
lated individually for each loaded sample. The expression levels are given as percentages of the intensity for cells transformed 
with Ad5 or Ad12 inactivated virus. Results for Ad5 E1A expression are from an average of six membranes and values for 
Ad12 E1A expression represent the average from seven membranes.
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yet was significantly up-regulated in Ad5-TC compared to
BRK cells. Therefore, it could be possible that either this
represents a unique effect of product(s) from the Ad5 E1
region on the p53-signalling pathway or that a unique
Ad12 E1 gene product is negating the effects of a gene
product common to both Ad5 and Ad12 E1 regions. The
role of ATM in neoplasia is not due to dysregulated levels
of expression: mutated ATM plays a role in neoplasia [45]
and the mouse ATM gene decreases the development of
neoplasia by acting through V(D)J recombination [46].
Down-regulation of GADD45B has been associated with
neoplasia [47]; however levels of GADD45B were not sig-
nificantly dysregulated in the BRK cell line stably trans-
formed by oncogenic Ad12 E1 in comparison to
untransformed BRK. The down-regulation of GADD45B
in Ad12 E1-TC compared to Ad5 E1-TC is due to signifi-
cant up-regulation of GADD45B by Ad5 E1 transforma-
tion, as previously discussed. Another dysregulated target
affected by p53 is TP53I13 (synonym DSCP1); a p53-
inducible gene with no GO annotation available (Addi-
tional file 1). Levels of TP53I13 were up-regulated over
1.5-fold in Ad5 E1-TC over Ad12 E1-TC and could be
exerting a tumour suppressor effect in these cells, as there
is in vitro evidence that such up-regulation retards cancer
cell growth [48].
Expression of collagen type I observed using immunofluorescence microscopy Figure 6
Expression of collagen type I observed using immunofluorescence microscopy. Immunofluorescence on cells 
stained for collagen type I (red) and nuclei staining with DAPI (blue) shows down-regulation of collagen as a result of transfor-
mation of BRK cells by Ad5 E1A (Panel A) or Ad12 E1A (Panel B) in comparison to untransformed rat fibroblast cell line 3Y1 
and human breast tumour derived cell line MCF7 (Panel C). Representative images of one field are shown with corresponding 
TRITC:DAPI ratio for the individual field. Expression levels were calculated relative to intensity in untransformed BRK cells 
(Panel D). The dark grey bars represent the microarray results and the white bars represent the real-time PCR results while 
the light grey bars represent the immunofluorescence microscopy results. Each bar represents average ratio of intensity (cor-
rected for background) of TRITC:DAPI for 10 fields imaged from same slide with significant results indicated by * (P < 0.500). 
Expression of collagen type I in MCF7 cells has been shown to vary according to the source of the cell line [86] and our results 
indicate variance on an individual cell basis (P 0.860).
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Another dysregulated target with no GO process available
is the family with sequence similarity 84, member B gene
(FAM84B; synonyms NSE2; BCMP101). FAM84B, usually
involved in formation of the DNA repair complex, is up-
regulated in breast cancer tissue, in which it localises to
areas of cell-to-cell contact where it interacts with and may
block the tumour suppressor function of the cell adhesion
protein α1-catenin [49]. Up-regulation of FAM84B has
also been reported in esophageal squamous cell carcino-
mas [50].
The microarray results suggested over 1.5-fold down-regu-
lation of TFAP2A in Ad12-TC compared to Ad5-TC. Tran-
scription factor activator protein-2 alpha has been
suggested as a candidate tumour suppressor protein, as
loss of TFAP2A protein in several human cancers is associ-
ated with enhanced tumorigenicity [51]. Loss of function
of TFAP2A in cancer cells could be due to hypermethyla-
tion of the CpG island from the human TFAP2A, which
strongly correlates with decreased expression of the gene
in neoplastic breast epithelial cells [51].
Not all of the targets listed in Table 1 were mapped by IPA.
One target of particular interest that was not mapped by
IPA was the microarray clone AI145841, identified as Rat-
tus norvegicus v-rel reticuloendotheliosis viral oncogene
Ingenuity network analysis of the dysregulation in Ad5 E1-TC compared to untransformed BRK cells Figure 7
Ingenuity network analysis of the dysregulation in Ad5 E1-TC compared to untransformed BRK cells. The high-
est scoring biofunctions associated with the five top scoring networks are summarised (a) with the significantly dysregulated 
transcripts (focus molecules) that mapped to each network listed. Significant overlap between networks was calculated for (b) 
networks 1 and 5, and (c) networks 2, 3 and 4: focus molecules are depicted as down-regulated (green) or up-regulated (red).
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homolog A (avian) by manual BLAST searching of the
non-redundant nucleotide database (100% query cover-
age, E-value: 3 × 10-70). RelA is a component of the NF-κB
complex and is involved in transcriptional regulation.
NFκB1 binds to RelA to form the p50 (NFκB1)/p65(RelA)
heterodimer, which activates transcription of many genes
in multiple tissues once phosphorylated on p65 by pro-
tein kinase A [52]. As approximately equal amounts of
p65 and p50 have been previously reported to exist within
the nuclei of Ad12 and Ad5-transformed cells [53,54], it
would be reasonable to assume that the expression of
RelA would not vary greatly as a result of Ad12-transfor-
mation. However, others have reported that Ad12 E1A
13S can block the proteolytic processing of the inhibitor
of NFκB (p105) resulting in unusually high levels of the
inhibitor within host cells that sequester NFκB to the cyto-
plasm [55]. In the cell lines transformed with either the
early region of Ad12 (Ad12 E1-TC) or Ad5 (Ad5 E1-TC),
as well as in cell lines transformed with either inactivated
Ad12 or Ad5 (Ad12-TC and Ad5-TC), levels of RelA tran-
scripts were slightly up-regulated compared to expression
in untransformed BRK cells (Figure 8c). At the protein
level, the up-regulation of RelA was least pronounced in
Ad12 E1A-TC (Figure 8c). If this was to occur in infected
Biological validation of microarray results by real-time PCR and Western Blotting Figure 8
Biological validation of microarray results by real-time PCR and Western Blotting. Expression levels of (a) protein 
phosphatase 1, regulatory (inhibitor) subunit 1A (PPP1R1A), (b) mixed lineage kinase 1 (MLK1, synonym MAP3K9) and (c) 
RelA were investigated at the RNA level by microarray analysis (dark grey bars) and real-time PCR (white bars) and at the pro-
tein level by Western Blotting (light grey bars). Examples of membranes stained for the target protein of interest then subse-
quently GAPDH are given. The average intensity ratio of target protein of interest to GAPDH (calibrated to that in 
untransformed BRK cells) was calculated using density of band signals. The microarray results were obtained from two copies 
of each membrane screened in duplicate. The real-time PCR results represent three RNA samples per cell-line run in triplicate.
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cells, Ad12 E1A could be acting to reduce the level of RelA
induction which would complement inhibition of the
tumour necrosis factor receptor 1 (TNFR1) signalling
pathway; such a block in proinflammatory or pro-apop-
totic signalling would be beneficial for viral persistence.
Other targets that were not mapped by IPA but were iden-
tified by manual BLAST searching include ZBTB22,
NFAT5 and SSG1. No GO information about biological
function is available for ZBTB22 (synonyms ZNF297 and
BING1), originally identified as a gene within the 70 kbp
segment flanking the TAPASIN locus on human chromo-
some 6 [56], within the extended collection of genes
known as the Major Histocompatibility Complex (MHC).
As ZBTB22 contains both a zinc finger domain and a POZ
domain, the suspected function is transcriptional repres-
sion. Figure 11 shows that there is good agreement
between the microarray and real-time PCR results, with
up-regulation of ZBTB22 in Ad5 E1-TC and, to a lesser
extent, in Ad12 E1-TC compared to untransformed BRK
cells. All of the genes assigned to the stress and immune
response category were found to be up-regulated in Ad5
Ingenuity network analysis of the dysregulation in Ad12 E1-TC compared to untransformed BRK cells Figure 9
Ingenuity network analysis of the dysregulation in Ad12 E1-TC compared to untransformed BRK cells. Overall, 
less dysregulation of transcripts in Ad12 E1-TC compared to untransformed BRK cells was found by the microarray study so 
not many focus molecules were returned by IPA (a). The top scoring network (b) contains two molecules associated with can-
cer; HOPX and PLAT.
1 x 10-3 Cancer, gastrointestinal disease, 
organismal injury and abnormalities
↓USP19 5
1 x 10-3 Cancer, skeletal and muscular 
disorders, gene expression
↓WDR36 4
1 x 10-3 Cell morphology, cell-to-cell signalling 
and interaction, cellular assembly and 
organisation
↑GPR125 3
1 x 10-3 Cardiovascular disease, nucleic acid 
metabolism, small molecule 
biochemistry
↑NUDT4  2
1 x 10-9 Cellular growth and proliferation, 
cancer, cardiovascular system 
development and function
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E1A-TC compared to either untransformed BRK cells or
Ad12 E1A-TC (Figure 2). These genes include NFAT5,
which was confirmed by real-time PCR results as being
up-regulated in Ad5 E1A-immortalised cells compared to
BRK cells (Figure 11).
Steroid sensitive gene 1 (SSG1; synonyms URB, CL2,
DRO1) was originally identified as an estrogen-regulated
gene whose over-expression correlated with rat mammary
carcinogenesis [57]. Subsequently, elevated expression of
URB was reported in the adipose tissue of a strain of mice
exhibiting mild late-onset obesity [58]. Our microarray
Ingenuity network analysis of the dysregulation in Ad12 E1-TC compared to Ad5 E1-TC Figure 10
Ingenuity network analysis of the dysregulation in Ad12 E1-TC compared to Ad5 E1-TC. The top five highest 
scoring networks are summarised (a) with the most significant associated network functions and focus molecules, and (b) there 
was considerable overlap between networks (shared molecules are indicated). The simplified merged network (c) gives an idea 
of the complicated cross-talk between networks 1, 2, 3, 4, 5 and 12, with molecules identified as down-regulated or up-regu-
lated by the microarray study depicted in green or red, respectively.
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results indicated significant up-regulation of SSG1 expres-
sion of over 1.5-fold in Ad5 E1-TC compared to Ad12 E1-
TC (Additional file 1). Given that Ad5 E1A has previously
associated with induction of CL2 in rat thyroid cells and
CL2 is down-regulated in human thyroid neoplastic cell
lines and tissues [59], it is tempting to consider this gene
as an important player in the process of neoplastic trans-
formation. The finding that DRO1 expression is down-
regulated following neoplastic transformation of an E1A-
immortalised rat kidney epithelial cell line (RK3E cells)
mediated by β-catenin provides further evidence for the
potential role of SSG1 in neoplastic progression [60].
Discussion
From the information obtained about the dysregulated
genes and the levels of expression determined by the
microarray study, a subset of six transcripts were selected
for further study at the mRNA level by real-time PCR on
the basis of involvement in the immune system and/or
possible involvement in oncogenesis. Expression levels of
mRNA transcripts were investigated in the Ad E1-TCs used
for the microarray study and also in BRK cells immortal-
ised with inactivated Ad12 (Ad12-TC) or Ad5 (Ad5-TC) or
Ad12 E1A (Ad12 E1A-TC) or Ad5 E1A (Ad5 E1A-TC).
Both these results and those from studies at the protein
level showed good agreement with the results obtained by
microarray.
Gene ontology analysis of the microarray results revealed
that the majority of classifiable dysregulated transcripts
were products from genes that play roles in signal trans-
duction and transcription (Figure 2). This is perhaps not
surprising as adenovirus is known to exert a pleiotropic
effect on cellular signalling pathways and perturb host cell
gene expression at the transcriptional level [reviewed in
[5]]. Our real-time PCR and Western blotting results con-
firmed dysregulation of PPP1R1A and MLK1, which play
roles in signal transduction pathways, and ZBTB22 and
RelA, involved in transcription processes.
The real-time PCR results did suggest highly increased
expression of PPP1R1A as a result of transformation with
Microarray results and corresponding RT-PCR results for ZBTB22 and NFAT5 expression in Ad-transformed cells Figure 11
Microarray results and corresponding RT-PCR results for ZBTB22 and NFAT5 expression in Ad-transformed 
cells. The microarray results for ZBTB22 indicating up-regulation of the transcript in Ad12 E1-TC were validated by real-time 
PCR. The microarray result for NFAT5 indicating significant up-regulation in Ad5 E1-TC (1.58-fold; table 1) was validated by 
real-time PCR. The down-regulation in Ad12 E1-TC indicated by the microarray study was not significant (0.17-fold; table 1) 
due to high variability (p-value; 0.635) and the real-time PCR results for expression of NFAT5 also did not indicate any signifi-
cant dysregulation of this transcript in Ad12 E1-TC, or Ad12-TC.
ZBTB22 NFAT5
Ad5-TC (real-time PCR)
Ad5 E1-TC (microarray)
Ad5 E1-TC (real-time PCR)
Ad12-TC (real-time)
Ad12 E1-TC (microarray)
Ad12 E1-TC ( real-time PCR)
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
f
o
l
d
-
d
i
f
f
e
r
e
n
c
e
 
r
e
l
a
t
i
v
e
 
t
o
 
u
n
t
r
a
n
s
f
o
r
m
e
d
 
B
R
K
 
c
e
l
l
 
l
i
n
e
*
*
*
*
*
*
*
*
*
*
*BMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
Page 16 of 24
(page number not for citation purposes)
inactivated Ad12 or the Ad12 E1 region alone; however,
this contradicts both the microarray and WB results,
which indicate no significant dysregulation in Ad12-TC,
Ad12 E1-TC or Ad12 E1A-TC. Significant up-regulation of
PPP1R1A was observed in Ad5-TC, Ad5 E1-TC and Ad5
E1A-TC so it is possible that this represents a unique effect
of products from the Ad5 region. Presumably, increased
expression of PPP1R1A would have a beneficial effect on
virus survival by altering one of the many other pathways
involving PP1; for example, the cell cycle. It is known that
Ad E1A directly binds to pRb and releases the E2F tran-
scription factor from pRb family-mediated repression
resulting in reprogramming of cells to enter S phase
[reviewed in [6]]. The increase in PPP1R1A could comple-
ment the Ad E1A mediated displacement of E2F from pRb
by preventing PP1 activating (dephosphorylating) pRb;
this would maintain cell cycle progression.
The results also indicated that another possible unique
effect of Ad5-transformation could be elevated expression
of MLK1. Perhaps the over-expressed levels of MLK1 in
Ad-transformed cells are causing preferential activation of
the JNK pathway, as indicated in Figure 12, leading to
transformation and anchorage-independent growth.
Levels of EGFR in Ad-transformed cells have already been
well-characterised. Over-expression of EGFR has been
observed in a variety of tumour types and it is thought that
this may induce aberrant signalling, giving rise to uncon-
trolled cellular growth [reviewed in [61]]. Several lines of
evidence suggest that the significant down-regulation of
EGFR observed in Ad5 E1-TC makes sense both in the
context of kidney cells and lack of oncogenicity of this Ad
serotype: over-expression of EGFR is associated with poor
prognosis and metastatic spreading of renal cancer
[62,63] and monoclonal anti-human EGFR antibody has
been found to increase delay in tumorigenesis of human
kidney cancer cell lines [64].
The effect on the development process of tumour cells
exerted by dysregulation of the other targets within these
categories is less well-defined. Interference of human
PAK4 mRNA by siRNA has been reported to decrease
anchorage-independent growth of HeLa cells [65], sug-
gesting that the observed down-regulation of PAK4 would
adversely affect anchorage-independent growth. Human
stathmin (STMN1) antisense DNA decreases the growth
of K562 cells [66], so possibly up-regulation of STMN1
has a stimulatory effect on growth. The effect of up-regu-
lation of MTA3 on the tumour cell line is even less clear:
Over-expressed levels of MLK1 could be causing preferential activation of the JNK pathway Figure 12
Over-expressed levels of MLK1 could be causing preferential activation of the JNK pathway. Rac1 or Cdc42 
relieves MLK1 autoinhibiton and allows MLK1 to dimerise, autophosphorylate and activate the MKK7/JNK/c-Jun pathway, and 
possibly the MKK4/p38 and MKK4/JNK/c-Jun pathways. Wild-type E1A Ad 12S is known to inhibit Ras-mediated activation of 
Rac1 and Cdc42. The E1B 19K protein can activate the MKK7/JNK/c-Jun pathway; this could possibly be via MLK1.
Ras
?
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as it is known that the fate determination of H929 cells is
dependent on MTA3 [67], perhaps MTA3 is playing a piv-
otal role in fate determination of the transformed BRK
cells. However, the high variance associated with the
duplicates for MTA3 suggests that the dysregulation may
not be significant (Additional file 1).
A particularly well-characterised effect of dysregulation of
host cell gene expression by Ad transformation of BRK
cells is the down-regulation of surface expression of MHC
Class I in Ad12-transformed rodent cells, which plays a
major role in the evasion of the rodent immune response
to Ad12-TC. It is known that the down-regulation of MHC
class I molecules on the cell surface of Ad12 E1-trans-
formed cells is due to decreased binding of NF-κB and
increased binding of the repressor COUP-TFII to the
enhancer, with the converse occurring in Ad5-trans-
formed cells [reviewed in [6]]. However, this is thought to
be due to the effect of Ad12 on the p50 component of
NFkB (as opposed to RelA) as hypophosphorylation of
p50 in Ad12-TC renders the NFκB heterodimer incapable
of binding DNA [68], so is not likely to be affected by dys-
regulation of levels of RelA by Ad transformation. How-
ever, it is possible that the less-marked increase in RelA
expression in Ad12 E1A-TC observed in this study could
be acting to complement inhibition of the TNFR1 signal-
ling pathway to prevent proapoptotic or proinflammatory
signalling.
However, it is important to appreciate that down-regula-
tion of MHC Class I alone does not govern oncogenesis. A
suggestion of the complexity involved is provided by the
fact that many genes that play roles in the stress and
immune response are also implicated in other pathways
within the cell: for example, NFAT5 and GADD45B.
The up-regulation of NFAT5 at the RNA level in Ad5-TC
was confirmed by real-time PCR, however the real-time
PCR results for the Ad12-TC were more variable (figure
11). The DNA binding domain of NFAT5 is thought to
have evolved from NF-κB and, as NFAT5 can be induced
by a wider range of stimuli than just the best characterised
one of osmotic stress, the protein is thought to be a poten-
tial player in a wide range of cell signalling pathways; for
example, studies in NFAT-5 deficient mice have suggested
roles in embryonic development, integrin-induced cellu-
lar migration, and proliferation [69].
GADD45B, another member of the stress and immune
response category, is up-regulated in normal cells in
response to environmental stresses, mediates p38/JNK
pathway activation by binding and activating MTK1/
MEKK4 kinase and has been found to regulate Cdc2 and
p21WAF1 activities, resulting in G1 arrest, inhibited cell
cycle progression, and apoptosis [70-72]. As down-regula-
tion of GADD45B is associated with neoplasia [47], it is
perhaps not surprising that GADD45B was found to be
significantly up-regulated in BRK cells stably transformed
with the non-oncogenic Ad5 E1 region (Additional file 1).
The other heavily populated GO categories contain genes
related to cell cycle and proliferation and matrix, cell
adhesion and the cytoskeleton: perhaps unsurprisingly, as
these processes are known to be altered by the transforma-
tion process. The real-time PCR and immunofluorescence
microscopy results confirmed the microarray study find-
ing that significant down-regulation of collagen type I,
alpha I occurs as a result of transformation of BRK cells
with both Ad5 E1A and Ad12 E1A. Collagen type I is a
major component of the extra cellular matrix (ECM) and
the observed down-regulation is presumably involved in
the loss of growth contact inhibition displayed by trans-
formed cells.
The lesser populated GO categories defined in Figure 2 are
no less important. For example, products of the Ad E1
region are known to be involved in subverting the host
cell apoptotic response to viral infection. Only four genes
related to apoptosis were found to be dysregulated by Ad
transformation. One of these, ZMAT3 (rat synonyms
PAG608 and WIG1), has been found to increase apoptosis
[73] and decrease growth of tumour cells [74]. The
ZMAT3 protein contains three zinc finger domains and a
nuclear localization signal. Wildtype p53 up-regulates
both mRNA and protein produced from the ZMAT3 gene.
As over-expression of ZMAT3 inhibits tumour cell growth,
a role for this gene in the p53-dependent growth regula-
tory pathway seems probable. Comparative analysis of all
dysregulated genes across the three cell lines revealed the
p53 canonical pathway to be significantly affected (Figure
4). This is unsurprising, given that p53 is central to
numerous pathways already known to be disturbed by
adenovirus transformation, as indicated in Figure 13.
Approximately 30% of identified genes had associated
GO processes that did not readily fall into any of the cate-
gories mentioned in Figure 2 (a full listing of these tran-
scripts is available in Additional file 1). The transcripts
which fall into this multifaceted 'other' category are nev-
ertheless important considerations in the conundrum of
what governs adenovirus transformation. For example:
tissue factor pathway inhibitor (TFPI) appears in two high
scoring networks (Figure 7a; network 2 and Figure 10a;
network 5) which share a degree of overlap with other sta-
tistically significant networks (Figures 7c and 10c). Cancer
is one of the top biofunctions associated with these
merged networks and two molecules dysregulated by Ad5
E1 transformation of BRK cells show a statistically signifi-
cant association with this category (p-value ranging from
2.62 × 10-9 to 2.8 × 10-4): TFPI and zinc finger matrin typeBMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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3 (ZMAT3). Up-regulation of TFPI mRNA is associated
with human metastatic colorectal cancer [40]. TFPI regu-
lates the proteolytic function of the TF-VIIa complex – a
major initiator of coagulation pathways involved in
wound healing in vivo [75]. Given that, pathologically,
human solid tumours such as colon cancer are character-
ised by desmoplasia and tumour stroma has been com-
pared to a 'wound that does not heal' [76], it is perhaps
unsurprising that the interaction of TFPI and TF-VIIa has
been implicated in tumour cell adhesion and migration
[77].
Conclusion
The classification of genes corresponding to RNA tran-
scripts that were found to be up-regulated by microarray
reported here demonstrates that many different processes
have been altered as a result of Ad transformation. This
underlines the difficulty in unravelling the cellular net-
works involved in the transformation process and onco-
genesis. The largest group were classified as genes
encoding for proteins involved in signal transduction.
One of the hallmarks of neoplastic growth is the deregu-
lation of cellular signalling pathways. It may be possible
Growth regulatory pathways of the host cell are perturbed by adenovirus Figure 13
Growth regulatory pathways of the host cell are perturbed by adenovirus. Ad proteins act on the host cell signalling 
network to uncouple DNA replication from anti-growth signals, senescence and apoptosis. Similar growth deregulation is 
caused as a result of tumour cell mutations. Therefore, viruses and viral proteins represent a natural system that is used to 
study growth deregulation programs with the aim of gaining insight into the process of carcinogenesis. Figure adapted from [5].
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in the future to gain insight into the dysregulation at the
protein level with advances in methods for producing
oncoproteomic and oncogenomic data sets and bioinfor-
matics. Our dataset serves as a starting point for further
investigation into dysregulation of host cell networks as a
result of adenovirus transformation. It is important to
note that the relative low number of entries limits the
comparative expression of genes dysregulated by Ad trans-
formation presented in this paper. In addition, the 15,481
unique genes screened by the microarray filters used in
this study represent 62% of the rat genome. As more is
found out about the rat genome, it is conceivable that data
relating to genes that are currently uncharacterised in this
study, for example those that lack clear identities or are
defined as ESTs, will yield more insights into the process
of adenovirus transformation. Further work is required to
investigate which splice variant of Ad E1A is responsible
for the observed dysregulation at the pathway level and
the mechanisms of E1A-mediated transcriptional regula-
tion.
Methods
Cell culture and extracts
Primary BRK cells were isolated from 5 to 7 day old Wistar
rats. The kidneys were removed aseptically, trypsinized,
and cells isolated from the tissue samples were seeded out
and harvested once sub-confluent [78]. Levels of mRNA
expression in the primary BRK cells were compared to
those in BRK cells transformed with the left-hand 16% of
the viral genome containing the E1 region of Ad12 (Ad12
E1-TC; the RFC-1 cell line, as described in [79]) or Ad5
(Ad5 E1-TC; the Ad5 Xho cell line). Levels of mRNA
expression were also examined by real-time PCR in clonal
BRK cell lines transformed with Ad12 (Ad12-TC; the
Ad12#1 cell line) or Ad5 (Ad5-TC; the Ad5#2 cell line) in
which the infectivity of the input virus had been reduced
by UV treatment. All four Ad-transformed rat cell lines
contained integrated copies of the respective transforming
(E1) region and expressed the transforming E1A and E1B
proteins ((K. Raska, personal communication and GEB,
unpublished results). In addition to the cell lines used in
the real-time PCR analysis, the expression levels of targets
at the protein level was also investigated using BRK cells
immortalised with Ad12 E1A only (Ad12 E1A-TC; the
AccIH cell line) and Ad5 E1A only (Ad5 E1A-TC; the
HpaIE cell line [17]). Expression levels were also assessed
in untransformed Fisher rat embryonic fibroblasts (3Y1
cell line). All transformed cell lines were maintained in
high glucose Dulbecco's Modified Eagle Medium
(DMEM) containing streptomycin (100 μg/ml), penicillin
(100 I.U./ml), L-glutamine (2 mM) and 10% foetal calf
serum (FCS; Invitrogen Ltd) in a humidified atmosphere
of 5% CO2 at 37°C.
For microarray and real-time PCR analysis, total RNA was
extracted from harvested primary BRK cells and trans-
formed cell lines by the Trizol method and resuspended in
RNase and DNase-free H2O. For Western blotting analy-
sis, total protein was isolated from subconfluent cells har-
vested in ice-cold PBS, centrifuged at 1500 rpm for 5 min
(Sorvall TC, Dupont) and resuspended in modified RIPA
buffer [30 mM HEPES-KOH, 150 mM NaCl, 1% Triton-
X100, 0.1% SDS, 1% sodium deoxycholate, 5 mM EDTA
(pH7.6)] supplemented with protease inhibitors (Com-
plete, Mini, EDTA-free protease inhibitor cocktail tablets,
Roche) and phosphatase inhibitors (phosphatase inhibi-
tor cocktails 1 and 2, Sigma) following the manufacturer's
instructions. Cells were lysed for 1 hr on ice and centri-
fuged at 13000 rpm for 5 min at 4°C. Supernatant was
assayed for protein concentration by the BioRad detergent
compatible (DC) protein assay (BioRad) using a standard
curve constructed from a dilution series of BSA in modi-
fied RIPA buffer.
Antibodies
The following antibodies were used for Western Blotting
(WB) or immunofluorescence microscopy: anti-Ad12 E1A
mouse monoclonal antibody provided as undiluted cul-
ture medium (163; kind gift from Dr R. Grand), for Ad12
E1A WB; mouse monoclonal adenovirus type 5 antibody
(M58; Abgent), for Ad5 E1A WB; anti-NF-κB (RelA) rabbit
polyclonal antibody (Ab-1; Calbiochem), for RelA WB;
purified rabbit polyclonal antibody (Abgent), for MLK1
WB; rabbit-anti-DARPP-32 affinity-purified antibody
(Chemicon), for PPP1R1A WB; anti-collagen, type I rabbit
polyclonal antibody provided as undiluted serum (Calbi-
ochem), for detection of COL1A1 by immunofluores-
cence microscopy.
Microarray experiments
Two different batches of the Rat GeneFilters® microarray
set comprising gf300, gf301 and gf302 (ResGen™, Invitro-
gen) were used in this study. Each genefilter comprises a
nylon membrane spotted with cDNA clones that have
been partially sequenced, verified against the GenBank
database using BLAST and cross-referenced to the Uni-
Gene database. In order to minimize false positives aris-
ing from non-specific cross-hybridisation, the first 1,000
base pairs from the 3' untranslated region (UTR) are
included in the cDNAs. In addition, each filter contains β-
actin control spots and total genomic DNA 'landing lights'
to enable correct orientation of each filter.
(i) Preparation of cDNA probe and microarray hybridization
Filters were pre-hybridised at 42°C for 2 h in 7.5 ml
MicroHyb buffer (ResGen™) containing 7.5 mg of heat
denatured mouse Cot-1 DNA (Invitrogen) and 7.5 mgBMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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GeneFilters primer poly dA. Each cell type was screened in
duplicate using cDNA from the same preparation. Briefly,
10 μg of total RNA from primary BRK cells, Ad5-E1 and
Ad12 E1 transformed BRK cells was reverse transcribed in
the presence of oligo(dT)12–18, 1.5 μl of a 20 mM equimo-
lar mix of dATP, dGTP and dTTP, and 10 μl [33P] dCTP (10
mCi/ml, specific activity 3000 Ci/mmol; ICN Radiochem-
icals). Following incubation with 1 μl of 0.1 M dithioth-
reitol, reaction buffer and 1.5 μl of Superscript II reverse
transcriptase (Invitrogen) at 37°C for 1.5 h, probes were
purified by chromatography on Bio-Spin-6 columns (Bio-
Rad) and hybridised to cDNA microarray membranes at
42°C for 16 h in MicroHyb solution (ResGen). Mem-
branes were washed twice for 20 min in 2 × SSC-1% SDS
at 50°C and once for 15 min in 0.5 × SSC-1% SDS at 55°C
and exposed to a phosphoimager plate for 48 hr.
(ii) Data collection, normalization and analysis
The arrays were scanned using a Molecular Dynamics
Storm Phosphoimager at a resolution of 50 μm. The data
were quantified by using the Pathways v.2.01 software
(Research Genetics). The data were normalised using the
average expression intensity of all of the spots on the filter
which gave results consistently centred on the ideal gene
expression ratio of 1, indicating no change between dupli-
cate samples. The data normalised with respect to all data
points was used in subsequent analysis and expression
levels below twice the background level were excluded.
Based on assessment of the relative sensitivity of the Gen-
eFilters arrays and the average experimental error, an
expression ratio of 1.5 was chosen to define genes that are
differentially expressed. The data discussed in this publi-
cation have been deposited at the EBI ArrayExpress web-
site and are accessible under the accession number E-
MTAB-30, in accordance with MIAME standards.
The rat genome has been sequenced since the construc-
tion of the arrays therefore bioinformatics analysis was
carried out to validate the results from the microarray
analyses. The accession numbers of cDNA clones from the
microarray data that corresponded to differentially regu-
lated genes were subjected to BLASTN searches against the
expressed sequence tag (EST) database. Returned EST gi
numbers were searched against BLASTN nr database to
identify corresponding mRNA record containing protein
and gene identity.
Initial information on pathways and gene ontology (GO;
[80]) functions of genes and proteins were obtained from
the database for annotation, visualisation and discovery;
DAVID [81], the Gene Map Annotator and Profiler; Gen-
MAPP [82], and the Kyoto Encyclopaedia of Genes and
Genomes (KEGG) databases integrated at GenomeNet
Database Service http://www.genome.jp/kegg/
genes.html.
The Ingenuity Pathways Analysis (Ingenuity Systems®,
http://www.ingenuity.com) applications were used to
generate networks and assess statistically relevant bio-
functions and canonical pathways associated with the
microarray data. A data set containing the accession num-
bers of microarray clones and corresponding expression
values was uploaded and mapped to corresponding genes
in the Ingenuity knowledge base to enable the construc-
tion of networks and analysis of biofunctions and canon-
ical pathways. A fold change cut-off of 1.5 was set to
identify genes whose expression was significantly differ-
entially regulated. These genes, called focus genes, were
overlaid onto a global molecular network developed from
information contained in the Ingenuity knowledge base.
Networks of these focus genes were then algorithmically
generated, based on their connectivity.
The BioFunctional analysis identified the biological dis-
eases that were most significant to the data set as a whole
(comparative analysis) or to the network. Genes from the
dataset (or network genes) that met the fold change cut-
off of 1.5 and were associated with biological diseases in
the Ingenuity knowledge base were considered for the
analysis. Fischer's exact test was used to calculate a p-value
determining the probability that each biological disease
assigned to that data set (or network) is due to chance
alone. The Functional Analysis of a network identified the
biological diseases that were most significant to the genes
in the network.
Canonical Pathways Analysis identified the pathways
from the Ingenuity Pathways Analysis library of canonical
pathways that were most significant to the dataset. Genes
from the dataset that met the fold change cut-off of 1.5
and were associated with a canonical pathway in the Inge-
nuity knowledge base were considered for the analysis.
The significance of the association between the dataset
and the canonical pathway was measured in two ways:
firstly, a ratio of the number of genes from the dataset that
met the expression value cut-off that map to the pathway
divided by the total number of molecules that exist in the
canonical pathway is displayed. Secondly, Fischer's exact
test was used to calculate a p-value determining the prob-
ability that the association between the genes in the data-
set and the canonical pathway is explained by chance
alone.
Quantitative real-time PCR
(i) Preparation of gene-specific PCR primers
Gene-specific primer pairs were designed using PrimerEx-
press version 1.5 software (Applied Biosystems) and pur-
chased from Eurogentec. The uniqueness of the designed
primer pairs was checked by a BLAST homology search
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi to ensure
that homologous genes were not cross-amplified by theBMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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same primer pair. Where possible, primers were designed
that span intron/exon boundaries, and a list of all primers
for target genes examined in this study is given in Table 1.
Rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used as a housekeeping mRNA and the
sequences for the forward and reverse primers
(RTPrimerDB identification number 192) were obtained
from the Real Time PCR Primer and Probe Database http:/
/medgen.ugent.be/rtprimerdb/index.php.
(ii) RNA preparation and first-strand cDNA synthesis
Following total RNA extraction, the RNA solution was
treated with RQ1 RNase-free DNase (Promega) and Rna-
seOUT Recombinant Ribonuclease Inhibitor (Invitro-
gen), following the manufacturer's instructions. Total
RNA samples were analysed by gel electrophoresis for the
presence of 28S and 18S rRNA. Purity and concentration
of RNA samples was determined by UV spectroscopy [as
described in 83]. First-strand cDNA synthesis (1 μg total
RNA per 20 μl reaction) was carried out with the ImProm-
II reverse transcription system (Promega) using an
oligo(dT) primer (Amersham Biosciences), following the
manufacturer's instructions. Reactions containing all rea-
gents except reverse transcriptase were performed for each
total RNA sample to test for the presence of contaminat-
ing DNA.
(iii) Real-time PCR
PCR amplification was carried out in 96-well plates with
adhesive covers using the ABI Prism 7900 HT instrument
(Applied Biosystems) for all targets except NFAT-5 which
was amplified using the GeneAmp 5700 thermocycler.
The efficiencies of target gene and GAPDH amplification
were investigated by performing a dilution series of total
RNA (1 μg to 0.1 ng) following recommendations [84].
Each 25 μl reaction contained: 12.5 μl 2 × SYBR Green
PCR master mix (Applied Biosystems), 1 μl forward
primer (10 μM), 1 μl reverse primer (10 μM) and 1 μl of
cDNA. Each sample was analysed in triplicate. To test for
the presence of contaminating DNA, 25 μl reactions con-
taining 1 μl RNAse DNase-free H2O in the place of either
1 μl reverse transcriptase or cDNA were analysed along-
side reactions containing reverse transcriptase and cDNA
for each sample. Each real-time PCR program was 2 min
at 50°C, 10 min at 95°C, followed by 40 repeats of 15 s
at 95°C and 1 min at 60°C. A final dissociation stage
added to each run (15 min at 95°C, 20 s at 60°C and 15
s at 95°C) enabled assessment of presence of contamina-
tion, primer-dimers or non-specific PCR products. Some
PCR products were also assessed by agarose gel electro-
phoresis.
(iv) Data analysis
Data was analysed by the 2-ΔΔCT method [85]. Any raw CT
values within the repeats that differed by a standard devi-
ation of > 0.3 were not included in the calculation of aver-
age CT [84]. The target transcript threshold cycle (CT)
values obtained from the SDS 2.2 software (Applied Bio-
systems) were normalised for GAPDH CT values to give
ΔCT. The comparative CT method was used to analyse the
real-time PCR data for targets with equal amplification. In
brief, the target transcript ΔCT values for the transformed
cells were expressed relative to the ΔCT values of the pri-
mary BRK cells to give ΔΔCT, and the fold change in
expression relative to the primary BRK cells was calculated
by 2-(ΔΔCT). Real-time PCR data obtained for NFAT5 ampli-
fication from the GeneAmp 5700 SDS software was
assessed by the standard curve method. The statistical sig-
nificance of the raw CT values representing differences in
mRNA expression levels between BRK cells and trans-
formed cells was determined by two-tailed student's t-test
assuming equal variances.
Western blot analysis
Isolated cell extract protein (Ad12 E1A WB: 60 μg/lane,
Ad5 E1A WB: 20 μg/lane, RelA WB: 20 μg/lane, MLK1 WB:
25 μg/lane, PPP1R1A WB 50 μg/lane) was diluted in red
loading buffer (NEB) containing 125 mM DTT (NEB),
heated at 100°C for 5 min and then applied to a 5% poly-
acrylamide stacking gel cast on top of resolving gel con-
taining a percentage of polyacrylamide dependent on the
molecular weight of target protein: Ad E1A and RelA,
10%; MLK1, 7.5%; PPP1R1A, 12.5%. After electrophore-
sis, the proteins were wet transferred onto either a polyvi-
nylidene difluoride membrane (Millipore, UK) for
AdE1A, RelA and MLK1 WBs, or nitrocellulose membrane
for PPP1R1A WBs, using a BioRad mini-gel block. The
membranes were treated overnight at 4°C with blocking
solution (Ad E1A and RelA WBs: 0.1% Tween-phosphate-
buffered saline [PBS-T] supplemented with 10% milk
powder, PPP1R1A WB: PBS-T supplemented with 5%
BSA, MLK1 WB: PBS-T supplemented with 3% BSA). The
membranes were washed in PBS-T. Samples were incu-
bated for 2 hr at room temperature with the primary anti-
body at an appropriate dilution (anti-Ad12 E1A, 1:100;
anti-Ad5 E1A, 1:400; anti-RelA, 1:5000; anti-MLK1,
1:500; anti-PPP1R1A, 1:1000) in PBS-T supplemented
with either 5% milk powder for Ad E1A and RelA WBs or
3% BSA for MLK1 and PPP1R1A WBs. The membranes
were washed for 30 min at room temperature with three
changes of PBS-T. Incubation with the secondary antibody
conjugated to horseradish peroxidase (Sigma) (anti-
mouse HRP for Ad E1A WBs; anti-rabbit-HRP for MLK1,
PPP1R1A and RelA WBs) was for 1 hr at room tempera-
ture, at appropriate dilutions (Ad E1A WBs, 1:1000; MLK1
WB, 1:50 000; PPP1R1A WB, 1:5000; RelA WB, 1:1000) in
same diluents as were used for primary antibodies. Mem-
branes were washed again for 30 min, imaged, washed
again for 30 min in PBS-T then incubated for 2 hr at room
temperature with an anti-GAPDH antibody (Calbiochem)BMC Genomics 2009, 10:67 http://www.biomedcentral.com/1471-2164/10/67
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diluted 1:20000 in PBS-T supplemented with 5% milk
powder. Incubation with the secondary antibody (anti-
mouse-HRP, Sigma), diluted 1:2000 in PBS-T supple-
mented with 5% milk powder, was for 1 hr at room tem-
perature. To detect HRP activity, advanced or normal ECL
reagents (Amersham) were used on membranes following
initial staining for target protein or subsequent staining
for GAPDH, respectively. Images were captured with a Fuji
LAS-3000 CCD camera (Fuji, Tokyo, Japan) and AIDA
image analysis software was used to determine band
intensities. The band intensities for target proteins were
corrected for background and normalised using GAPDH
expression calculated for the same lane.
Immunofluorescence microscopy
Cells were cultured in six-well plates containing sterile
coverslips until they were approximately 70% confluent,
washed twice with PBS and incubated with Sigma Fix (1
ml/well) at room temperature for 5 min. Cells were
washed twice with PBS and incubated at room tempera-
ture with 1% Triton X-100 in PBS (1 ml/well) for 10 min.
Cells were washed once with PBS and incubated at room
temperature for 10 min with 10 mM ammonium bicarbo-
nate in PBS (1 ml/well). Cells were washed twice with PBS
and blocked with 10% NGS in PBS (PBSngs) at 37°C for 1
hr. Samples were incubated for 1 hr at room temperature
with gentle shaking with the primary anti-collagen anti-
body, diluted 1:60 in PBSngs. The cells were washed several
times with PBS and secondary antibody was pipetted care-
fully onto each coverslip. Following 30 min incubation at
room temperature in the dark with anti-rabbit TRITC
diluted 1:100 in PBSngs, coverslips were washed several
times with PBS with DAPI in the final wash and trans-
ferred onto slides sample side down. Coverslips were
mounted with a drop of mounting medium (Vectashield
Hardset; Vector Laboratories Inc, USA) and edges were
sealed with clear nail varnish. Cells were viewed with an
Axioplan 2 microscope (Carl Zeiss Ltd, UK) using phase
contrast and UV epifluorescence techniques. Captured
images were analysed using AxioSet software (Carl Zeiss
Ltd, UK) to calculate the mean intensities of the Texas Red
and DAPI signals from ten separate fields taken from each
slide. The mean intensity signal for collagen was corrected
for background and normalised using DAPI intensity
from the same field.
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